Arvinas, Inc. ( ARVN) - Stock Earnings
ARVN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
ARVN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -67.4 million USD | 9.5 million USD |
| 2026Q1 | -57.6 million USD | 15.6 million USD |
| 2026Q2 | 169.4 million USD | 249.7 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ARVN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -367.3 million USD | 78.5 million USD |
| 2024 | -198.9 million USD | 263.4 million USD |
| 2025 | -80.8 million USD | 262.6 million USD |
| 2026 Est. | — | — |
ARVN
Price: $6.97
Earnings Per Share: 0.26 USD
P/E Ratio: 33.65
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 476209
Market Capitalization: 480.7 million